NCT01655225 2022-04-08A Study of LY3023414 in Participants With Advanced CancerEli Lilly and CompanyPhase 1 Completed156 enrolled
NCT03301207 2019-12-05A Study to Evaluate the Effect of Ibrutinib on the Pharmacokinetics of Oral Contraceptives, CYP2B6, and CYP3A4 Substrates in Female Participants With B Cell MalignancyJanssen Research & Development, LLCPhase 1 Completed25 enrolled
NCT01026415 2014-12-18Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35)Seagen Inc.Phase 1 Completed73 enrolled